23 May 2017

Prospero House, 241 Borough High Street, London

Final Agenda

The meeting will start promptly at 10am and is expected to finish at approximately 6pm.

Please note that this agenda is a draft and is subject to change prior to the meeting.

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Code of conduct for members of the public attending the meeting – Part 1 only (open session)
  3. Apologies – Part 1 only (open session)
  4. Any other business – Part 1 only (open session)
  5. Minutes from the last Committee meeting held on 20 April 2017 – Part 1 only (open session)
  6. Appraisal of beta interferon and glatiramer acetate for treating multiple sclerosis (review of TA32) [ID809]
    • 6.1. Declarations of interest – Part 1 only (open session)
    • 6.2. Introduction by Chair, Dr Amanda Adler – Part 1 only (open session)
    • 6.3. Presentation by the Chair, Dr Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  7. Appraisal of bisphosphonates for preventing osteoporotic fragility fractures (including a partial update of NICE technology appraisal guidance 160 and 161) [ID782]
    • 7.1. Declarations of interest – Part 1 only (open session)
    • 7.2. Introduction by Vice-Chair, Dr Sanjeev Patel – Part 1 only (open session)
    • 7.3. Presentation by the Vice-Chair, Dr Sanjeev Patel – Part 1 AND part 2 (open and closed session)
    • 7.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  8. Appraisal of cabozantinib for previously treated advanced renal cell carcinoma [ID931]
    • 8.1. Declarations of interest – Part 1 only (open session)
    • 8.2. Introduction by Chair, Dr Amanda Adler – Part 1 only (open session)
    • 8.3. Presentation by the Chair, Dr Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 8.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

To print an agenda, please right click and select 'Print' from the menu.

Date, time and venue of next meeting

The next meeting will take place on 21 June 2017 in London (venue TBC).

Please note all timings are approximate.

How to register

  • Click on the register link below and complete the registration form, selecting the topics you would like to attend.
  • You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
  • Registration will close on 11 May 2017Please note that it may not be possible to accept late requests. 
  • Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Josh South.
  • Registrants wishing to conduct a research study on committee meetings and/or NICE processes will require prior permission. Contact the NICE Enquiry Handling team at nice@nice.org.uk.
  • Further information about conducting research is also available in our common questions and answers about meetings in public document.

 

Registration period: 26 April 2017 to 11 May 2017
Registration is closed.